Literature DB >> 9581567

Superagonistic behaviour of epidermal growth factor/transforming growth factor-alpha chimaeras: correlation with receptor routing after ligand-induced internalization.

A E Lenferink1, R H Kramer, M J van Vugt, M Königswieser, P P Di Fiore, E J van Zoelen, M L van de Poll.   

Abstract

Human epidermal growth factor (EGF) and human transforming growth factor alpha (TGF-alpha) are structurally related polypeptide growth factors that exert their mitogenic activity through interaction with a common cell-surface receptor, the epidermal growth factor receptor (EGFR). The biological effect induced by these two ligands is quantitatively similar in most cases; in some test systems, however, TGF-alpha functions as a more potent form of EGF. In this study, we have compared EGF, TGF-alpha and ten previously described chimaeras of these two ligands in terms of their ability to generate a mitogenic response in cells carrying the human EGFR, and observed that three of the mutant growth factors (E3T, E4T and T3E4T) are mitogenic at concentrations 10-fold lower than that of either wild-type EGF or TGF-alpha. No difference in tyrosine kinase activity of the receptor towards an external substrate was observed after binding of the various mutants. It has been established before [Ebner and Derynck (1991) Cell Regulation 2, 599-612] that EGF and TGF-alpha differ in the processing of the receptor-ligand complex after internalization, as a result of their different pH sensitivities of receptor binding. Similar measurements on our chimaeric mutants revealed that the above superagonists show an enhanced pH dependence of binding in comparison with EGF. Furthermore, induction of receptor recycling by these superagonists is largely comparable with that induced by TGF-alpha. No superagonistic behaviour was observed on a cell-line containing an EGFR/erbB-2 chimaera which does not show ligand-induced internalization. These data show that EGF/TGFalpha chimaeras can be more active than the naturally occurring ligands, and that receptor recycling after ligand-induced internalization seems to be a prerequisite for this phenomenon.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9581567      PMCID: PMC1218868          DOI: 10.1042/bj3270859

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  39 in total

1.  Epidermal growth factor and transforming growth factor-alpha: differential intracellular routing and processing of ligand-receptor complexes.

Authors:  R Ebner; R Derynck
Journal:  Cell Regul       Date:  1991-08

2.  Fusions to staphylococcal protein A.

Authors:  B Nilsson; L Abrahmsén
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

3.  Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor.

Authors:  A B Schreiber; M E Winkler; R Derynck
Journal:  Science       Date:  1986-06-06       Impact factor: 47.728

Review 4.  Endocytosis of growth factor receptors.

Authors:  A Sorkin; C M Waters
Journal:  Bioessays       Date:  1993-06       Impact factor: 4.345

5.  The interaction of an epidermal growth factor/transforming growth factor alpha tail chimera with the human epidermal growth factor receptor reveals unexpected complexities.

Authors:  S M Puddicombe; L Wood; S G Chamberlin; D E Davies
Journal:  J Biol Chem       Date:  1996-11-29       Impact factor: 5.157

6.  The purification of fully active recombinant transforming growth factor alpha produced in Escherichia coli.

Authors:  M E Winkler; T Bringman; B J Marks
Journal:  J Biol Chem       Date:  1986-10-15       Impact factor: 5.157

7.  Kinase activity controls the sorting of the epidermal growth factor receptor within the multivesicular body.

Authors:  S Felder; K Miller; G Moehren; A Ullrich; J Schlessinger; C R Hopkins
Journal:  Cell       Date:  1990-05-18       Impact factor: 41.582

8.  Engineering epidermal growth factor for enhanced mitogenic potency.

Authors:  C C Reddy; S K Niyogi; A Wells; H S Wiley; D A Lauffenburger
Journal:  Nat Biotechnol       Date:  1996-12       Impact factor: 54.908

9.  Identification of the high affinity binding site of transforming growth factor-alpha (TGF-alpha) for the chicken epidermal growth factor (EGF) receptor using EGF/TGF-alpha chimeras.

Authors:  R H Kramer; A E Lenferink; I L van Bueren-Koornneef; A van der Meer; M L van de Poll; E J van Zoelen
Journal:  J Biol Chem       Date:  1994-03-25       Impact factor: 5.157

10.  Signal transduction by epidermal growth factor occurs through the subclass of high affinity receptors.

Authors:  L H Defize; J Boonstra; J Meisenhelder; W Kruijer; L G Tertoolen; B C Tilly; T Hunter; P M van Bergen en Henegouwen; W H Moolenaar; S W de Laat
Journal:  J Cell Biol       Date:  1989-11       Impact factor: 10.539

View more
  6 in total

1.  The linear C-terminal regions of epidermal growth factor (EGF) and transforming growth factor-alpha bind to different epitopes on the human EGF receptor.

Authors:  A E Lenferink; A D De Roos; M J Van Vugt; M L Van de Poll; E J Van Zoelen
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

2.  The ubiquitin-specific protease USP2a prevents endocytosis-mediated EGFR degradation.

Authors:  Z Liu; S M Zanata; J Kim; M A Peterson; D Di Vizio; L R Chirieac; S Pyne; M Agostini; M R Freeman; M Loda
Journal:  Oncogene       Date:  2012-06-18       Impact factor: 9.867

3.  Association of ErbB2 Ser1113 phosphorylation with epidermal growth factor receptor co-expression and poor prognosis in human breast cancer.

Authors:  X Ouyang; T Gulliford; H Zhang; G Smith; G Huang; R J Epstein
Journal:  Mol Cell Biochem       Date:  2001-02       Impact factor: 3.396

4.  Fates of endocytosed somatostatin sst2 receptors and associated agonists.

Authors:  J A Koenig; R Kaur; I Dodgeon; J M Edwardson; P P Humphrey
Journal:  Biochem J       Date:  1998-12-01       Impact factor: 3.857

5.  Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers.

Authors:  A E Lenferink; R Pinkas-Kramarski; M L van de Poll; M J van Vugt; L N Klapper; E Tzahar; H Waterman; M Sela; E J van Zoelen; Y Yarden
Journal:  EMBO J       Date:  1998-06-15       Impact factor: 11.598

6.  Non-Ligand-Induced Dimerization is Sufficient to Initiate the Signalling and Endocytosis of EGF Receptor.

Authors:  George Kourouniotis; Yi Wang; Steven Pennock; Xinmei Chen; Zhixiang Wang
Journal:  Int J Mol Sci       Date:  2016-07-25       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.